发明名称 |
PHARMACEUTICAL COMPOSITION FOR INHIBITING IMMUNE RESPONSE THROUGH INDUCING DIFFERENTIATION INTO REGULATOR T CELLS AND PROMOTING PROLIFERATION OF REGULATOR T CELLS |
摘要 |
The present invention relates to new medical use of (tetrahydropyran-4-yl)-[2-phenyl-5-(1,1-dioxo-thiomorpholine-4-yl)methyl-1H-indol-7-yl]amine, and more particularly, to a pharmaceutical composition containing the compound as an active ingredient, which is used for inhibiting an immune response, and/or for inducing differentiation into regulator T cells from undifferentiated T cells and/or promoting proliferation of regulator T cells. |
申请公布号 |
US2016051558(A1) |
申请公布日期 |
2016.02.25 |
申请号 |
US201414779812 |
申请日期 |
2014.03.25 |
申请人 |
LG LIFE SCIENCES LTD. |
发明人 |
CHO Seok Goo;KIM Na Youn;KIM Eun Jung;IM Keon Il;LIM Jung Yeon;JEON Eun Joo |
分类号 |
A61K31/541;C12N5/0783;A61K45/06;A61K35/17;A61K39/395;A61K38/18 |
主分类号 |
A61K31/541 |
代理机构 |
|
代理人 |
|
主权项 |
1. A pharmaceutical composition for suppressing immune response, comprising (tetrahydropyran-4-yl)-[2-phenyl-5-(1,1-dioxo-thiomorpholin-4-yl)methyl-1H-indol-7-yl]amine, a pharmaceutically acceptable salt or isomer thereof. |
地址 |
Seoul KR |